Submit manuscript...
eISSN: 2373-6372

Gastroenterology & Hepatology: Open Access

Review Article Volume 14 Issue 4

Acute uncomplicated diverticulitis: guidelines on diagnosis and management: is everything fine?

Sergio Morini MD

Correspondence: Sergio Morini MD, UPMC-Salvator Mundi International Hospital, Rome, Italy

Received: July 20, 2023 | Published: August 28, 2023

Citation: Sergio M. Acute uncomplicated diverticulitis: guidelines on diagnosis and management: is everything fine? Gastroenterol Hepatol Open Access. 2023;14(4):127-133. DOI: 10.15406/ghoa.2023.14.00557

Download PDF

Abstract

The transition from intravenous (IV) antibiotic therapy to oral therapy and the observation that in patients with acute uncomplicated diverticulitis (AUD), treatment with or without antibiotics gave similar results in both hospitalized and outpatients, opened the way for out-of-hospital treatment in selected patients with CT-confirmed diagnosis. Due to economic constraints and a growing demand for hospitalization, home hospital care (HAH) and other community-based services was supported to alleviate the burden on emergency departments (EDs). This resulted in significant cost savings for the National Health Service (NHS) but, in many countries, community services are not uniformly present, leading to health care inequality. Relationships between hospital and community doctors indicate poor professional communication. Shared guidelines could lead to increased adherence. Some conditional recommendations based on low-certainty evidence related to the diagnosis and management of AUD remain controversial. Even after recovery from an episode, the question of whether to pursue conservative management or elective surgery is still open for debate. The outpatient treatment is understood as referring to both patients managed by hospital doctors and those treated by general physicians in their office. On management and outcomes of patients with AUD diagnosis in primary care there is little data. AUD treatment without antibiotics encounters resistance in many countries for multiple reasons, including low implementation and uncertain dissemination of guidelines recommendations. This would require greater control and commitment on the part of Institutional bodies and scientific societies.

Social and health aspects in home care assistance

Since the 1940s, home care for the elderly has been a social value in Canada. However, skepticism about the capabilities of families to supply care and poor institutional planning hindered its development for decades. It was only when home treatment was found to be more cost-effective than hospitalization that the Health System began to support it, prioritizing health and cost saving over original social concerns.1 In Ireland, the concept of outpatient treatment2 took shape in the emergency departments (ED) in the last years of the past century to cope with the rapid increase in hospitalization requests for pediatric or elderly patients suffering from various acute or subacute diseases.3 The initial interest was primarily economic, with a focus on providing lower-cost out-of-hospital services as part of the Hospital-Based Home Care Program (HBPC).4

In the United States, home care service was very active in the 1930s but declined significantly in the 1950s. Subsequently the expansion of hospital-at-home services was due to multiple factors, including cost containment, quality of care, excessive demand for hospitalization, lack of acute inpatient services, and satisfaction among patients and their families with home treatment.5 Furthermore, the forecast of Medicare cost reductions made it necessary to plan and finance new hospital-based home care methods of diagnosis and treatment.2,5–8

Antibiotics

In 1952 an “in office” study of patients with diverticulosis, documented by barium enema, found that 75 developed an unequivocal clinical picture of acute diverticulitis. All were treated with sulfonamides, with good results in 71. All except 4 were treated at home. Of the 4 who were hospitalized, only one required surgery. The conclusion was that if patients with diverticulitis are treated early, they rarely require surgical intervention.9 Unlike studies conducted in a hospital setting, this one was carried out in private primary care and did not receive the attention it deserved.

In 1994 Sarin reported that 85% of the patients admitted who responded to the standard conservative IV antibiotic treatment, had a good outcome, with a recurrence rate of 2% per year at a median 48 months follow up. His conclusion was that in patients with conservative management, routine elective operation was not justified.10

The turning point in Europe and western countries, where diverticulitis mostly affects the left colon, came in 2007 with Hjern’s report11 showing that antibiotics are not mandatory for mild diverticulitis. In hospitalized patients, conservative treatment with or without antibiotics had comparable outcomes, with recurrence or subsequent surgery rates of 28% and 29% respectively, at a mean follow-up of 30 months. However, the study was retrospective, and patients treated with antibiotics had more pronounced blood, clinical, and CT inflammatory parameters. So, the results warranted further randomized prospective studies.

In 2010, Etzioni confirmed the effectiveness of outpatient treatment in 94% of cases with initial acute diverticulitis diagnosed in ED room visit and confirmed by CT. The study found that risk factors for failure (6%), defined as a return to the emergency room or an admission for diverticulitis within 60 days, were female gender and the presence of free fluid on a CT scan.12 Failure will then be defined in such a varied way as to constitute one of the factors of heterogeneity between studies.

A retrospective study on AUD confirmed the effectiveness of chemotherapy in outpatient setting and found that ambulatory oral antibiotic treatment was viable in 73% of patients with CT confirmed AUD and that only 3% of them needed admission.13

The requirements for outpatient treatment included the ability to tolerate oral intake, the absence of signs of systemic inflammatory response, no severe comorbidities, and family or social support allowing adequate monitoring. Priority was given to the absence of immune compromise, for the high risk of severe outcomes, which required hospitalization and antibiotic treatment.14,15 The antibiotic treatment in AUD was gradually defined based on evidence16 concerning the efficacy and savings of the oral route,17–19 the type and combination of antibiotics,20 and the short vs the alternative courses of 7-10 or, 14 days.11,12,20,21

No antibiotic treatment

In 2012, the RCT Avod and, later, the Diabolo study, albeit with limitations, highlighted the efficacy of conservative treatment without antibiotics in AUD.22,23 A Cochrane review aimed to evaluate the effects of antibiotics on relevant outcomes in AUD, concluded that the newest evidence from a single RCT needed confirmation from more RCTs before it could be safely “implicated” in clinical guidelines (16). Nevertheless, at about the same time, Danish guidelines reversed the traditional indication of mandatory use of antibiotics, arguing that there was no evidence of their beneficial effect in AUD. Antibiotics were to be used only in selected cases depending on the global clinical situation. Moreover, considering that clinical diagnosis may not be accurate stated that CT scan could confirm it and define its severity and guide treatment.24 Even guidelines issued by Dutch scientific societies took a stand on the adequacy of treatment without antibiotics in selected mild cases. Nevertheless, their indication was that pain, absence of vomiting and C-reactive protein >50 mg/l were highly predictive of AUD. In the absence of signs of complication imaging could be avoided.25

Outpatient treatment

A subsequent review evaluating the safety and effectiveness of home treatment with oral antibiotics (with a maximum hospital stay of 24 hours and further ambulatory or HAH assistance) found that failure rates (6.5% vs. 4.6%, p=0.32) and recurrence rates (13.0% vs. 12.1%, p=0.81) were similar between outpatient and inpatient care. Failure of medical treatment included the need for prolonged antibiotic treatment or admission for radiological or surgical intervention.

A meta-analysis was not possible due to the heterogeneity of the studies, but the conclusion was that outpatient treatment without antibiotics was adequate in selected patients, with a daily saving per patient of between 690 and 1,868 euros.26 These results are in line with those of previous and subsequent studies. Nevertheless, some concerns arose, especially about a trend for a higher number of overall (9.0% vs. 5.0%) or elective (7.7% vs. 4.2%) interventions in the observational group compared to the antibiotic treatment group at 24 months, as well as many limitations in the study design.27 This statistically non-significant difference in sigmoid resection (5.0% vs. 2.5%, p=0.21) was confirmed by pooling the 12-month data from the Avod and Diabolo trials.28 Moreover, a meta-analysis including only randomized trials found that elective sigmoid resection was significantly more frequent in the observational than in the antibiotic group (2.5% vs. 0.9%; p = 0.04) during follow-up.19

In 2018, van Dijk et al conducted a meta-analysis on 2303 people and, while supporting the effectiveness and safety of the outpatient setting (7% readmission and 0.2% emergency surgery), underlined that the studies concerned only cases of left AUD. Moreover, only the Diver trial18 was a multicenter RCT23,29–31 guidelines adherence.

Besides the known studies limitations it was confirmed that the potential cost reduction of outpatient treatment, between 42 and 82%, compared to hospitalized patients had not been adequately implemented in clinical practice in many countries32 and that only a few guidelines had changed their recommendations on this point.33–35

As for acute diverticulitis, in the US from 2002 to 2007 emergency admission rate increased by 9.5% but only 12.2% of patients underwent urgent surgical resection equal to a 4.3% increase but, unexpectedly, elective surgery increased by 38.7%.36,37 Even a population-based analysis using administrative data from 2002 to 2012 reported an increase in admissions for complicated acute diverticulitis and a reduction in urgent surgery (from 28% to16%).37 In some countries, instead, this trend reversed in the same period. In Iceland, although from 1985 to 1995 the incidence of admissions and resections for sigmoid diverticulitis increased, from that year until 2014 the incidence of hospitalization for diverticulitis decreased, particularly for elderly patients.38

The increase in outpatient care reduced the number of inappropriate hospitalizations. In the US, while the number of visits for diverticulitis in the ED increased, admission rates dropped from 58.0% in 2006 to 47.1% in 2013, and bowel surgeries decreased by 33.7% in relation to visits for diverticulitis.39 Data from the Italian Hospital Information System, from 2008 to 2015, found a progressive increase in hospitalizations for complicated AUD. The emergency surgery rate increased by 3.9% per year. Also in this study there was a significant increase of 38% in elective surgery.40 According to the 2014 ASCRS guidelines,41 elective resection after AUD had to be considered only on a case-by-case basis. In the US elective sigmoidectomy continued to increase after the 2006 guidelines with an annual trend of 1.16% up to 2015. Only later there was a progressive adaptation to the new guidelines.42,43

In Canada, population-based administrative data showed that elective surgery after discharge for acute diverticulitis decreased from 9.6% in 2002 to 3.9% by 2011, besides shorter stays, had produced savings.37,44 Thus, the reduction of hospitalizations and surgical interventions for AUD were determining factors in healthcare cost reduction, estimated at between 35% and 83% compared to traditional hospitalization.18,26,32,45

Inequalities in access, treatment, and outcomes are related to economic, educational, and ethnic factors46,47 and are observed even in countries where medical care was guaranteed to everyone. The Swedish National Hospital Registry showed that among patients with diverticular disease, an increased risk of hospitalization, more frequent laparotomy, and complications were more frequently associated with low social status, advanced age, peripheral location, or in patients without private insurance.48–50 Regarding acute diverticulitis Previous studies in outpatients51 or in both inpatients and outpatients,52 treated without antibiotics found good results in short term follow up. From 2002 to 2007 in the United States, the rate of emergency admissions increased by 9.5%, but only 12.2% of patients, an increase of 4.3%, underwent urgent surgery. Surprisingly, the number of elective surgeries increased by 38.7%.37 Also, a population-based analysis using administrative data from 2002 to 2012 reported an increase in admissions for complicated acute diverticulitis and a decrease in urgent surgeries (from 28% to 16%) and an increase in percutaneous drainage.37 However, this trend was reversed in some countries. In Iceland, the incidence of admissions and resections for sigmoid diverticulitis increased from 1985 to 1995, but from that year to 2014, the incidence of hospitalization for diverticulitis decreased, especially in older patients.38

More recently, the long-term results of the AVOD trial confirmed efficacy and safety of outpatients’ treatment with or without antibiotics at a median follow up of 11 years. In Van Dijk ST et al.28 and the same conclusion was confirmed by another meta-analysis.53 The randomized, multicenter DINAMO trial also confirmed that no antibiotic treatment is effective and no inferior to current standard treatment in AUD.54

Subgroups

As for subgroups, the presence of significant comorbidities in outpatients treated with antibiotics did not affect outcomes in meta-analyzes or single studies,29,45 although it should be noted that more than 80% of studies included only patients in their first acute episode, while patients with high ASA scores were excluded.30

In their editorial Flum and Read point out the paucity of evidence in the literature data, the resulting weakness of guideline recommendations, and the low adherence to these recommendations. Currently, there are no global scores that have individual prognostic value for the outcome of diverticulitis. With subgroup evaluation that includes genetic data on other characteristics, it will be possible to obtain stronger evidence. The committee ASCRS CPG advocates a "large, randomized trial comparing surgery and medicine in diverticulitis (COSMID)” that has not yet recruited patients and aims to better clarify the outcomes of conservative and surgical treatment of diverticulitis. The primary endpoint is assessment of overall health at one-year follow-up

It is important to note that 80% of patients with diverticula have no symptoms. Diverticulum is only an epiphenomenon of the multiple morpho-functional changes of the colon wall. However, some patients, about 20%, complain of abdominal symptoms essentially characterized by non-transient pain in the left iliac fossa, along with more nonspecific symptom or, more rarely, acute diverticulitis 10% of which is complicated or with sequelae. AI is likely to support research into individual predictive factors by processing thousands of clinical, environmental, metabolomics, and increasing genomic data.56

Despite the economic benefits, adherence to outpatient treatment has been slow and inconsistent, although in a meta-analysis between 40% and 62.6% of patients were enrolled for this management after an assessment in the ED.31,57 In a 2011 web-based survey of gastroenterologists and surgeons in the Netherlands, 90% of respondents treated mild diverticulitis without antibiotics, and most of them “would consider” outpatient treatment."58 and in Sweden, adherence to outpatient management without antibiotics increased from 20% to 60% between 2011 and 2014, with good clinical outcomes and a reduction in healthcare costs.51,58,59

Reality shows large discrepancies on this issue. While in Ireland in 2014-16 the national Hospital In-Patient Inquiry (HIPE) reported that only 4.6% of diverticulitis admitted were complicated, in a single institution 40.5% of diverticulitis admitted had complications.60

In a recent consensus conference of the European Association of Endoscopic Surgery (EAES) and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) on the management of acute diverticulitis. Approximately 88% of members agreed with the recommendation that AUD can be treated with mild symptoms on an outpatient basis; 65% stated that this was already their daily practice; in contrast, 20.80% disagreed that this would likely change their practice, while 59.12% agreed with the recommendation to consider trying no antibiotic therapy in immunocompetent individuals with AUD and 50% disagreed that this would likely lead to a change in their practice.61

Health care services in the community and HAH

As mentioned earlier, attempts have been made to reduce disparities in health care. Over time, many forms of home, clinical, or community-based care services have emerged, varying both between and within countries: Health Homes, Nursing Centers, Outpatient Parenteral Antibiotic Therapy (OPAT), Health Homes, community health centers and other modalities that are integrated into the various health care systems.

Instead, at the 2023 World Congress in Barcelona, it was reaffirmed HAH peculiarity as an acute hospital service with a responsible hospitalist supported by a multidisciplinary team; patients are treated at home as if they were in hospital; diagnostic services can be accessed urgently; remote monitoring of patients can be provided through home therapies and remote patient monitoring. Unlike other hospital services, support extends to 24 hours a day, expanding patient eligibility.62

The development of international platforms, such as The World Hospital at Home Community, has facilitated the sharing of new experiences and the implementation of new solutions for home care. The cost-benefit ratio is beneficial for both the healthcare system and the patient and his family. However, this activity must be understood as one of other hospital and community services. The lack of integration between these services could mean that the imbalances observed in hospitalization remain in the outpatient setting.63

Reorganization of services and common procedures are a prerequisite for better and uniform health care and compliance with the guidelines. In Italy, the proposed differentiated regional autonomies, with an inconsistent financial commitment and local organization, risk disregarding the principle of equal social and health care throughout the national territory.64 Another aspect to consider is the distinction between the roles of hospital physicians and community-based physicians as poor interprofessional collaboration is often observed. Joint participation in the development of the guidelines would undoubtedly improve adherence.

Regarding outpatient treatment, recent guidelines update two aspects, concerning diagnosis (imaging) and treatment in the outpatient setting (with or without antibiotics). A review of the guidelines on these two aspects shows indications that are not consistent.

Imaging

Regarding the CT scan, the American Gastroenterological Association (AGA) Clinical Practice Update65 reported as the first best practice advise that imaging should be considered to confirm the diagnosis in patients without current documentation because the clinical diagnosis alone may be incorrect.66,67 However, this rule has problems with applicability in primary care; Imaging requires hospital access or community facilities, which are absent or inadequate in many countries.

Although recommendations vary in strength,68–70 the guidelines emphasize the importance of performing a CT scan or US examination to confirm the diagnosis. The European Society of Coloproctology (ESCP)68 guidelines also consider imaging “essential” for treatment decisions in both secondary and primary care. The American College of Physicians (ACP) instead suggests CT scan “when diagnostic uncertainty” exists" (conditional recommendation; low certainty evidence).71

In contrast to the American Society of Colon and Rectal Surgeons (ASCRS) (70), WSES suggests a staged approach beginning with a US examination, whereas the German guidelines72 advocate that imaging should be performed when diverticulitis is suspected. NICE and the guidelines of the Italian National Guideline System73,74 recognize the diagnostic value of early imaging and the possibility of immediate initiation of adequate therapy and outpatient setting. Finally, the greatest dissent is found in the EAES and SAGES). Regarding the recommendation of selective imaging in patients suspected of having AUD, 42% of members stated that this was already their practice and 18% would change their practice. In contrast, 45% did not think it was likely that their practice would change.61 However, even on this topic is likely that current attitudes toward imaging will soon change due to AI support.75

In primary care, on the other hand, imaging is not considered essential for clinical suspicion of mild AUD imaging, although some concerns are expressed. The most common objection is that in most studies, diagnoses were confirmed by imaging. In primary care setting it is difficult to quickly perform CT in the context of the NHS. Sonography, which would be easier to obtain and would be an alternative to CT in primary care, has objective diagnostic limitations out of specialized departments.70,76 Thus, blood tests can be quite informative, when performed.

Outpatient treatment with oral antibiotics proved to be a viable and effective option in 2/3 of patients presenting to the hospital with AUD, and this approach was successful in 94%. Complication and recurrence rates were like those obtained in hospitalized patients treated with IV antibiotics.77 According to ACP and AGA, the efficacy of antibiotic treatment on the left side AUD is similar between outpatients and inpatients with low evidence. There is still insufficient evidence for some important clinical outcomes such as treatment failure, mortality, or emergency surgery.

The quality of evidence is low, and more studies are needed to obtain more precise effect estimates.71,78 Future studies should also consider the antibiotic spectrum to limit bacterial resistance, side effects, and costs.79 Otherwise, WSES and ASCRS indicate that selected patients with uncomplicated diverticulitis can be treated without antibiotics (strong recommendation based on high-quality evidence, 1A). The result of the survey in which SAGES participated was particularly divergent. In addition, the assessment of the German guidelines72 is that in mild cases, even if CT is not performed, it is not clear why antibiotics should be given because their efficacy is not evident in AUD. For AGA, antibiotic treatment can be used selectively and not routinely in immunocompetent patients with mild AUD uncomplicated diverticulitis.

Recent guidelines recommend a wait-and-see approach with initial patient monitoring. Clear fluids or a light meal and analgesics are usually recommended, and in many cases, physicians are already using this observational approach without antibiotics.

Primary care

Most cases of AUD, which are visited to the doctor's office, refer to patients with mild symptoms, often only pain, can eat and move, and have help at home. In these cases, there should be no problem prescribing analgesics and a liquid or light diet for 24 hours, with a warning to report if the symptoms worsen. This treatment is widely used in northern Europe and other countries, but not elsewhere. Not surprisingly, many physicians consider giving antibiotics when diverticulitis is suspected.

Among the different reasons there is that not prescribing antibiotics in an acute phase would seem a paradox for doctors frequently prescribing them for mild symptoms. This widespread practice has also led patients to expect such treatment. Another reason is the fear of medicolegal aspects, considering that their prescription is still usual treatment for patients with diverticula. However, there are individual situations in which GPs must decide whether to use antibiotics or not, such as in the presence of "significant" comorbidities. It is unclear whether and when heart disease or T2 diabetes - which account for 50% of comorbidities57 or chronic obstructive pulmonary disease (COPD), which “increases the risk of infection”, require antibiotics. On this point, there is often poor interprofessional collaboration between primary care physicians and other health care professionals, which is a barrier to adherence to the guidelines.80

More detailed recommendations are needed to avoid doctors using antibiotics as the default option when in doubt. Moreover, when necessary, which antibiotics, dosage and duration of treatment should be suggested in guidelines?

The patients most seen in the office are the mildest cases for whom unnecessary referral can be avoided. But what happens next? We do not know how many of them had imaging, were referred to a specialist, received antibiotics or were hospitalized. Nonetheless, they are unlikely to have a worse outcome than patients referred to the hospital and discharged as outpatients. In the absence of confirmatory tests, it is not known how many cases are actually diverticulitis so there are no relevant data on their diagnosis, treatment, and outcome.

Indirect data comes from a study of patients who were presented to the ED or to outpatient clinics. In the two approaches an urgent CT scan was performed in 85% versus 15%; an abnormal EBC count was found in 69% versus 35%; and inpatient admission within 24 hours occurred in 30% versus 3.5% of patients’ respectively.81

An Italian study of primary care physicians in patients with diverticular disease found that about 13% were referred to specialists. Of symptomatic diverticular patients, 3.4% had an admission related to diverticular problems. Only 13% had a previous diagnosis of diverticular disease. Nevertheless, rifaximin was prescribed in 61% of cases and ciprofloxacin in 7.6%.82

In a small recent study evaluating compliance with NICE guidelines on antibiotic prescription, was carried out an electronic search. Among diagnoses of diverticulosis or diverticular disease, in 42% of the visits, presenting complaints were considered as “suspicious of diverticulitis.” In further (one or more) consultations, antibiotics were prescribed in 68% of cases; approximately 12% of visits resulted in a referral for surgical evaluation, and blood tests were required in 19.3% of cases. Of note, only 3.5% of cases returned within 48 hours as recommended, while 3.5% of patients worsened and were hospitalized.83 Although these are sparse data, adherence to guidelines seems to be very low, especially regarding antibiotics. The authors question whether diverticulitis should be managed in primary care.

The answer would be complex given that these cases are very frequent and that low adherence to guidelines, particularly about antibiotic use, is not new, is ubiquitous and can be observed in both hospital and primary care settings, although for different reasons.80 Indeed, to assess compliance with NICE guidelines for antibiotic use in CT-confirmed AUD in the ED was found that all 20 patients with a National Early Warning Score (NEWS) of low risk were prescribed antibiotics. The conclusion in this case was the need for greater awareness of the guidelines.84

Furthermore, to evaluate antibiotic use in primary care, prescriptions in patients with diverticular disease were monitored for 8.9 years after acute or non-acute hospitalization and in matched inpatient controls. The result was that antibiotic use in primary care not only doubled over the years after an acute admission compared with controls but was also higher before admission.85

Implementation and dissemination

The problem of inadequate adherence to guidelines affects the levels of the health care system, the organization, and the individual.

A recent "review of systematic reviews" aimed to identify the most frequently cited barriers and facilitators to the implementation of adherence to clinical practice guidelines in primary care. Among the six categories identified, the most frequently cited barriers included suboptimal healthcare network and interprofessional communication, applicability, motivation, and time.86 Implementation refers to the adoption of new procedures or the application of new evidence that simplifies a process and allows for improved efficiency by reducing errors, time, and costs. However, the process is not quick. The time in which 5-10% of recommendations enter clinical practice is calculated as 17 years.87

Implementation activities include, among others, many educational programs and feedback mechanisms. This assumes that the process of disseminating guidelines was adequate. Dissemination occurs, among many channels, through publication in “reputable” journals, medical conferences, and meetings, in institutional and professional organizations, in the media, and through professional channels.88 It should be considered, however, that less prestigious journals can also be a good vehicle for disseminating inaccurate messages.

In a recent article, Hawkins addresses the specific issue of antibiotic treatment in AUD and asks a rhetorical question, “Why are we still using antibiotics for uncomplicated diverticulitis in North America?”.89

The question is pertinent, but circumscribed, because it is the same old question asked in other countries.90 for example in Italy, where the use of antibiotics is higher than the European average. Among the many valid explanations, he and others cite I would like to focus on dissemination91 through medical conferences and meetings, where the message conveyed sometimes sounds unclear. It will be difficult to change the habit of diffuse antibiotic treatment when people with diverticula are cyclically prescribed antibiotics: in 61% of cases after acute diverticulitis, in 47% of cases with abdominal pain diagnosed as SUDD, and even in 20.6% of asymptomatic people in which some diverticula were discovered by accident.92 Considering that the latter group has a diverticulitis risk of 4.3% during an 11-year follow-up period, equivalent to 6 cases per 1000 patient-years and even lower when only confirmed cases are considered,93 it is legitimate to wonder whether the dissemination was appropriate and in accordance with the guidelines or whether the message was misperceived by the audience. Institutional and professional organizations could curb this “unbalanced force”.

Acknowledgments

None.

Conflicts of interest

The author declare no conflicts of interest.

Funding

None.

References

  1. Struthers J. "No place like home": Gender, family, and the politics of home care in post-world war II Ontario. Can Bull Med Hist. 2003;20(2):387–417.
  2. Lumsdon K. No place like home? Market signs show that home care may eclipse hospital care. Hosp Health Netw. 1994;68(19):44–46.
  3. Jayabose S, Escobedo V, Tugal O, et al. Home chemotherapy for children with cancer. Cancer. 1992;69(2):574–579.
  4. Ritchie CA, Thomas DR. Home-based primary care in the VA setting, with a focus on Birmingham, Alabama. J Long Term Home Health Care. 1998;17(4):18–25.
  5. Bentur N. Hospital at home: What is its place in the health system? Health Policy. 2001;55(1):71–79.
  6. Church L. Positioning hospital-based home care agencies for managed care. Healthc Financ Manage. 1996;50(2):28–32.
  7. Sawyer RH, Patel U, Horrocks W. Domiciliary radiography: an important service? Clin Radiol. 1995;50:51–55.
  8. Leff B, JR Burton. Future directions: alternative approaches to traditional hospital care-home hospital. Clin Geriatr Med. 1998;14(4):851–861.
  9. Horner J. A study of diverticulitis of the colon in office practice. Gastroenterology. 1952;21(2):223–229
  10. Sarin S, Boulos PB. Long-term outcome of patients presenting with acute complications of diverticular disease. Ann R Coll Surg Engl. 1994;76(2):117–120.  
  11.  Hjern F, Josephson T, Altman D, et al. Conservative treatment of acute colonic diverticulitis: Are antibiotics always mandatory? Scand J Gastroenterol. 2007;42(1):41–47.  
  12. Etzioni DA, Chiu VY, Cannom RR, et al. Outpatient treatment of acute diverticulitis: rates and predictors of failure. Dis Colon Rectum. 2010;53(6):861–865.
  13. S Alonso, M Pera, D Parés, et al. Outpatient treatment of patients with uncomplicated acute diverticulitis. Colorectal Dis. 2010;12(10 Online):e278–282.
  14. Detry O, Honoré P, Meurisse M, et al. Diverticulosis and diverticulitis in the immunocompromised patients. Acta Chirurgica Belgica. 1999;99(3):100–102.
  15. Javier S González, José Luis LP, Laura Román GL. Diverticulitis in immunodeficient patients: our experience in the management of high-risk patients. Rev Esp Enferm Dig. 2020;112(1):47–52.
  16. Shabanzadeh DM, Wille Jørgensen P. Antibiotics for uncomplicated diverticulitis. Cochrane Database Syst Rev. 2012;11:CD009092.
  17. Ribas Y, Bombardó J, Aguilar F, et al. Prospective randomized clinical trial assessing the efficacy of a short course of intravenously administered amoxicillin plus clavulanic acid followed by oral antibiotic in patients with uncomplicated acute diverticulitis. Int J Colorectal Dis. 2010;25(11):1363–1370.
  18. Biondo S, Golda T, Kreisler E, et al. Outpatient versus hospitalization management for uncomplicated diverticulitis: a prospective, multicenter randomized clinical trial (DIVER Trial). Ann Surg. 2014;259(1):38–44.
  19. Mege D, Yeo H. Meta-analyses of current strategies to treat uncomplicated diverticulitis. Dis Colon Rectum. 2019;62(3):371–378.
  20. Kellum JM, Sugerman HJ, Coppa GF, et al. Randomized prospective comparison of cefoxitin and gentamicin-clindamycin in the treatment of acute colonic diverticulitis. Clin Ther. 1992;14(3):376–384.
  21. Schug-Pass C, Geers P, Hügel O, et al. Prospective randomized trial comparing short-term antibiotic therapy versus standard therapy for acute uncomplicated sigmoid diverticulitis. Int J Colorectal Dis. 2010; 25:751–759.
  22. Chabok A, Pahlman L, Hjern F, et al. Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis. Br J Surg. 2012;99:532–539.
  23. Daniels L, Unlu C, de Korte N, et al. Randomized clinical trial of observational versus antibiotic treatment for a first episode of CT-proven uncomplicated acute diverticulitis. Br J Surg. 2017;104:52–61.
  24. Andersen JC, Bundgaard L, Elbrønd H, et al. Danish national guidelines for treatment of diverticular disease. Dan Med J. 2012;59(5):C4453.
  25. Andeweg CS, Mulder IM, Felt-Bersma RJ, et al. Guidelines of diagnostics and treatment of acute left-sided colonic diverticulitis. Dig Surg. 2013;30(4–6):278–292.
  26. Balasubramanian I, Fleming C, Mohan HM, et al. Out-Patient management of mild or uncomplicated diverticulitis: a systematic review. Dig Surg. 2017;34(2):151–160.
  27. Peery AF. It's actually a little complicated: antibiotics for uncomplicated diverticulitis. Am J Gastroenterol. 2018;113(7):949–950
  28. Van Dijk ST, Chabok A, Dijkgraaf MG, et al. Observational versus antibiotic treatment for uncomplicated diverticulitis: an individual-patient data meta-analysis. Br J Surg. 2020;107(8):1062–1069.
  29. Unlu C, Gunadi PM, Gerhards MF, et al. Outpatient treatment for acute uncomplicated diverticulitis. Eur J Gastroenterol Hepatol. 2013;25(9):1038–1043.
  30. Isacson D, Smedh K, Nikberg M, et al. Long-term follow-up of the AVOD randomized trial of antibiotic avoidance in uncomplicated diverticulitis. Br J Surg. 2019;106(11):1542–1548.
  31. ST van Dijk, Daniels L, Ünlü Ç, et al; Dutch diverticular disease (3D) collaborative study group. Long-term effects of omitting antibiotics in uncomplicated acute diverticulitis. Am J Gastroenterol. 2018;113:1045–1052.
  32. ST van Dijk, Bos K, de Boer MGJ, et al. A systematic review and meta-analysis of outpatient treatment for acute diverticulitis. Int J Colorectal Dis. 2018;33(5):505–512.
  33. Binda GA, Cuomo R, Laghi A, et al. Practice parameters for the treatment of colonic diverticular disease: Italian society of colon and rectal surgery (SICCR) guidelines. Tecnologia Coloproctol. 2015;19:615–626.
  34. Kruis W, Germer CT, Leifeld L, et al. Diverticular disease: guidelines of the German society for gastroenterology, digestive and metabolic diseases and the German society for general and visceral surgery. Digestion. 2014;90:190–207.
  35. Sartelli M, Catena F, Ansaloni L, et al. WSES guidelines for the management of acute left sided colonic diverticulitis in the emergency setting. World J Emerg Surg. 2016;11:37.
  36. Masoomi H, Buchberg BS, Magno C, et al. Trends in diverticulitis management in the United States from 2002 to 2007. Arch Surg. 2011;146(4):400–406.
  37. Li D, Baxter NN, McLeod RS, et al. Evolving practice patterns in the management of acute colonic diverticulitis: a population-based analysis. Dis Colon Rectum. 2014;57:1397–1405.
  38. Alexandersson BT, Stefánsson T. Incidence and recurrence rate of sigmoid diverticulitis in patients requiring admission to hospital in Iceland from 1985 to 2014: nationwide population-based register study. BJS Open. 2020;4(6):1217–1226.
  39. Bollom A, Austrie J, Hirsch W, et al. Emergency department burden of diverticulitis in the USA, 2006–2013. Dig Dis Sci. 2017;62(10):2694–2703.
  40. Amato A, Mataloni F, Bruzzone M, et al. Hospital admission for complicated diverticulitis is increasing in Italy, especially in younger patients: a national database study. Tech Coloproctol. 2020;24(3):237–245.
  41. Feingold D, Steele SR, Lee S, et al. Practice parameters for the treatment of sigmoid diverticulitis. Dis Colon Rectum. 2014;57:284–294.
  42. Strassle PD, Kinlaw AC, Chaumont N, et al. Rates of elective colectomy for diverticulitis continued to increase after 2006 guideline change. Gastroenterology. 2019;157(6):1679–1681.
  43. Simianu VV, Bastawrous AL, Billingham RP, et al. Addressing the appropriateness of elective colon resection for diverticulitis: a report from the SCOAP CERTAIN collaborative. Ann Surg. 2014;260(3):533–538;discussion 538–539
  44. O'Leary DP, Myers E, Andrews E, et al. Changes in outcome and management of perforated diverticulitis over a 10 year period. Acta Chir Belg. 2012;112(6):436–440.
  45. Jackson JD, Hammond T. Systematic review: outpatient management of acute uncomplicated diverticulitis. Int J Colorectal Dis. 2014;29(7):775–781.
  46. Tong JKC, Mascuilli T, Wirtalla C, et al. Exploring ethnic differences in post-discharge patterns of surgical care for older adults admitted with diverticulitis. Colorectal Dis. 2023;19.
  47. Agresta F, Ansaloni L, Baiocchi GL, et al. Laparoscopic approach to acute abdomen from the consensus development conference of the societa Italiana di Chirurgia Endoscopica e nuove tecnologie (SICE), Associazione Chirurghi Ospedalieri Italiani (ACOI), Societa Italiana di Chirurgia (SIC), Societa Italiana di Chirurgia d’Urgenza e del Trauma (SICUT), Societa Italiana di Chirurgia nell’Ospedalita Privata (SICOP), and the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2012;26:2134–2164.
  48. Nikberg M, Ji J, Leppert J, et al. Socioeconomic characteristics and comorbidities of diverticular disease in Sweden 1997-2012. Int J Colorectal Dis. 2017;32(11):1591–1596.
  49. Lemini R, Spaulding AC, Osagiede O, et al. Disparities in elective surgery for diverticulitis: identifying the gap in care. Am J Surg. 2019;218(5):899–906.
  50. Mills AM, Holena DN, Kallan MJ, et al. Effect of insurance status on patients admitted for acute diverticulitis. Colorectal Dis. 2013;15(5):613–620.
  51. Isacson D, Thorisson A, Andreasson K, et al. Outpatient, non-antibiotic management in acute uncomplicated diverticulitis: a prospective study. Colorectal Dis. 2015;30(9):1229–1234.
  52. Estrada Ferrer O, Ruiz Edo N, Hidalgo Grau LA, et al. Selective non-antibiotic treatment in sigmoid diverticulitis: is it time to change the traditional approach? Tech Coloproctol. 2016;20:309–315.
  53. Desai M, Fathallah J, Nutalapati V, et al. Antibiotics versus no antibiotics for acute uncomplicated diverticulitis: a systematic review and meta-analysis. Dis Colon Rectum. 2019;62(8):1005–1012.  
  54. Mora López L, Ruiz Edo N, Estrada Ferrer O, et al. Efficacy and safety of nonantibiotic outpatient treatment in mild acute Diverticulitis (DINAMO-study): a multicentre, randomised, open-label, noninferiority trial. Ann Surg. 2021;274(5):e435–e442.
  55. Flum DR, Read TE. Evidence-based management of diverticular disease: what’s new and what’s missing? Dis Colon Rectum. 2020;63(6):715–717.
  56. Haug CJ, Drazen JM. Artificial intelligence and machine learning in clinical medicine, 2023. N Engl J Med. 2023;388(13):1201–1208.
  57. Cirocchi R, Randolph JJ, Binda GA, et al. Is the outpatient management of acute diverticulitis safe and effective? A systematic review and meta-analysis. Tech Coloproctol. 2019;23(2):87-100.
  58. Korte N, Klarenbeek BR, Kuyvenhoven JP, et al. Management of diverticulitis: results of a survey among gastroenterologists and surgeons. Colorectal Dis. 2011;13(12):e411–417.
  59. Isacson D, Andreasson K, Nikberg M, et al. Outpatient management of acute uncomplicated diverticulitis results in health-care cost savings. Scand J Gastroenterol. 2018;53(4):449–452.
  60. Reynolds I S, O'Connell E, Heaney R M, et al. The outpatient management, although optimal, did not seem usual and widely practicable. Ir J Med Sci. 2018;187(1):59–64.
  61. Francis NK, Sylla P, Abou Khalil M, et al. EAES and SAGES 2018 consensus conference on acute diverticulitis management: evidence-based recommendations for clinical practice. Surg Endosc. 2019;33(9):2726–2741.
  62. Withehead D, Conley J. The next frontier of remote patient monitoring: hospital at home. J Med Internet Res. 2023;25:e42335.
  63. N Bentur. Hospital at home: What is its place in the health system? Health Policy. 2001;55(1):71–79.
  64. International Health. Differentiated autonomy in healthcare. 2022.
  65. Peery AF, Shaukat A, Strate LL. AGA clinical practice update on medical management of colonic diverticulitis: expert review. Gastroenterology. 2021;160(3):906–911.
  66. Lameris W, van Randen A, van Gulik TM, et al. A clinical decision rule to establish the diagnosis of acute diverticulitis at the emergency department. Dis Colon Rectum. 2010;53(6):896–904.
  67. Andeweg CS, Knobben L, Hendriks JC, et al. How to diagnose acute left-sided colonic diverticulitis: proposal for a clinical scoring system. Ann Surg. 2011;253(5):940–946.
  68. Schultz JK, Azhar N, Binda GA, et al. European society of coloproctology: guidelines for the management of diverticular disease of the colon. Colorectal Dis. 2020;22(Suppl2):5–28.
  69. Hall J, Hardiman K, Lee S, et al. The American Society of colon and rectal surgeons clinical practice guidelines for the treatment of left-sided colonic diverticulitis. Dis Colon Rectum. 2020;63(6):728–747.
  70. Sartelli M, Weber DG, Kluger Y. et al. 2020 update of the WSES guidelines for the management of acute colonic diverticulitis in the emergency setting. World J Emerg Surg. 2020;15:32.
  71. Balk EM, Gaelen P Adam 1, Monika Reddy Bhuma, et al. Diagnostic imaging and medical management of acute left-sided colonic diverticulitis: A systematic review. Ann Intern Med. 2022;175(3):379–387.
  72. Kruis W, Germer CT, Böhm S, et al. German guideline diverticular disease/diverticulitis: Part II: conservative, interventional and surgical management. United European Gastroenterol J. 2022;10(9):940–957.
  73. National Institute for Health and Care Excellence (NICE). Evidence reviews for non-surgical management of acute diverticulitis. London: 2019.
  74. National Institute for Health and Care Excellence (NICE). Diverticulosis and colon diverticular disease: diagnosis and treatment. London: 2022.
  75. Rajpurkar P, Lungren MP. The current and future state of AI interpretation of medical images. N Engl J Med. 2023;388(21):1981–1990.
  76. Ripollés T, Sebastián Tomás JC, Martínez Pérez MJ, et al. Ultrasound can differentiate complicated and noncomplicated acute colonic diverticulitis: a prospective comparative study with computed tomography. Abdom Radiol (NY). 2021;46(8):3826–3834.
  77. Moya P, Bellon M, Arroyo A, et al. Outpatient treatment in uncomplicated acute diverticulitis: 5-year experience. Turk J Gastroenterol. 2016;27(4):330–335
  78. Dichman ML, Rosenstock SJ, Shabanzadeh DM. Antibiotics for uncomplicated diverticulitis. Cochrane Database Syst Rev. 2022;6(6):CD009092.
  79. Fletcher JC. The DINAMO study: efficacy and safety of non-antibiotic outpatient treatment in mild acute diverticulitis. REBEL EM blog. 2022.
  80. Rawlinson C, Carron T, Cohidon C, et al. An overview of reviews on interprofessional collaboration in primary care: barriers and facilitators. Int J Integr Care. 2021;21(2):32.
  81. O'Connor ES, Leverson G, Kennedy G, et al. The diagnosis of diverticulitis in outpatients: on what evidence? J Gastrointest Surg. 2010;14(2):303–308.
  82. Ubaldi E, I Grattagliano I, Lapi F, et al. Overview on the management of diverticular disease by Italian general practitioners. Dig Liver Dis. 2019;51(1):63–67.
  83. Kiandee M, Sripada R. Should diverticulitis be managed in primary care? an audit on the management of diverticulitis in primary care. Br J Gen Pract. 2020;70(1):bjgp20X711665.  
  84. Lesi O, Iqbal MR, Khan L. Diverticular disease: an audit of adherence to nice guidelines. Cureus. 2022;14(10):e30786.
  85. Broad JB, Wu Z, Ng J, et al. Diverticular disease management in primary care: how do estimates from community-dispensed antibiotics inform provision of care? PLoS One. 2019.
  86. Wang T, Tan JB, Liu XL, et al. Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews. BMJ Open. 2023;13(1):e062158.
  87. Rubin R MA. It takes an average of 17 years for evidence to change practice—the burgeoning field of implementation science seeks to speed things up. JAMA. 2023;329(16):1333–1336.
  88. Grol R. Improving patient care. The implementation of change in clinical practice. Oxford: Elsevier; 2005:290.
  89. Hawkins AT. Fighting Inertia: why are we continuing to treat acute uncomplicated diverticulitis with antibiotics? Ann Surg. 2021;274(5):e443–e444.  
  90. Zullo A, Hassan C, Maconi G, et al. Cyclic antibiotic therapy for diverticular disease: a critical reappraisal. J Gastrointestin Liver Dis. 2010;19(3):295–302.
  91. Brownson RC, Eyler AA, Harris JK, et al. Getting the word out: new approaches for disseminating public health science. J Public Health Manag Pract. 2018;24(2):102–111.
  92. Cremon C, Carabotti M, Cuomo R, et al. Italian nationwide survey of pharmacologic treatments in diverticular disease: Results from the REMAD registry. United European Gastroenterol J. 2019;7(6):815–824.
  93. Shahedi K, Fuller G, Bolus R, et al. Long-term risk of acute diverticulitis among patients with incidental diverticulosis found during colonoscopy. Clin Gastroenterol Hepatol. 2013;11(12):1609–1613.
Creative Commons Attribution License

©2023 Sergio. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.